The effect of clonazepam to reduce anxiety

Evaluation of preoperative clonazepam to reduce anxiety of patients referred to the Department of Surgery, Shiraz Dental School

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201012195420N1

Enrollment

Registered

2011-06-18

Start date

2010-12-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety. Phobic anxiety disorders

Interventions

Intervention 1: One dose of clonazepam 2 m.g one hour before surgery. Intervention 2: Placebo one hour before surgery.

Treatment - Drugs

Placebo

One dose of clonazepam 2 m.g one hour before surgery

Placebo one hour before surgery

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: patients referred to the Department of Surgery, Shiraz Dental School. Exclusion Criteria: children and people under 18; addicts; smoking; all systemic diseases; women during menstruation; and all drugs consumers.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Anxiety. Timepoint: 1 hour. Method of measurement: Visual Analogue Scale.;Blood pressure. Timepoint: 1 hour. Method of measurement: mm HG by using a Digital Manometer.;Pulse rate. Timepoint: 1 hour. Method of measurement: number per minutes by Digital Pulse Oximetry.;Oxygen saturation of blood. Timepoint: 1 hour. Method of measurement: percent by Digital Pulse Oximetry.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNavid Arasteh

Shiraz Dental School

arastehn@sums.ac.ir+98 71 1626 2193

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026